BioSpace News Archive

Leading breast cancer specialists to share best practices on leveraging the latest in cancer therapies to enhance patient care and minimize virus exposure

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, announced that the company will hold a webcast on Friday, June 5, 2020 at 8.30 a.m. to present additional results and analyses from its Phase 3 trial in negative symptoms.

Health care associated infections or surgical site infections are the infections acquired among patients during their hospital stay, creating needs for surgical infection control.

Transparency Market Research has published a new report titled ‘Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global bone grafts and substitutes market was valued at US$ 2.7 Bn in 2017.

Pressure infusion bags are a lifesaver for millions of patients around the world each year.

Induced pluripotent stem cells hold profound potential in replacing the use of embryonic stem cells as important tool for drug discovery and development, disease modeling, and transplantation medicine.

Hydrogen breath test analyzer refers to a highly sensitive and specific diagnostic tool that is used by gastroenterologists to eliminate or confirm the chances of short intestinal bacterial overgrowth or carbohydrate malabsorption.

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, announced that it intends to offer and sell 12,500,000 American Depositary Shares in an underwritten public offering.

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

Emergent and HHS expand 2012 CIADM public-private partnership with task order valued at approximately $628 million for rapid domestic production of leading COVID-19 vaccine candidates through 2021